 |
Lisa Ashby
President, Category Management, Cardinal Health |
 |
Tim Biro
Chief Operating Officer, On Target Labs; VP Business Development, GenomOncology |
 |
Greg Blackmore
Chief Operating Officer,
Midmark |
 |
Thomas Boat, M.D.
Dean of College of Medicine, V.P. for Health Affairs, University of Cincinnati
|
 |
Mark A. Collar,
Partner, Triathlon
Medical Ventures
Chairman |
 |
John F. Lewis, Jr.
Interim President,
BioOhio |
 |
Frank L. Douglas,
Ph.D., M.D.
President & CEO, Austen BioInnovation Institute in Akron
|
 |
Jacob Drapkin
Vice President, Reimbursement & Healthcare Economics, US Management Board,
Ethicon Endo-Surgery.
|
 |
Brian Duncan, M.D., MBA
Vice President Business Development, BioEnterprise
|
 |
John (Jack) Fisher
Executive Vice President, Ohio Farm Bureau Federation |
 |
John Gorski
President & CEO, NAMSA |
 |
Mike Hooven
President & CEO,
Enable Medical Technologies |
 |
Peter G. Kleinhenz
General Partner, CID Equity Partners & Venture Partner,
Fletcher Spagt Ventures |
 |
Barbara Kunz
Former President, Health and Life Sciences Global Business,
Battelle
|
 |
John M. Rice, Ph.D.
Past Board Chair,
Managing Partner, Triathlon Medical Ventures |
 |
David R. Scholl, Ph.D. Vice Chair
Partner, Athenian Venture Partners |
 |
Mike Sieron
President & CEO,
DG Medical |
 |
Caroline Whitacre, Ph.D.
Board Chair
Vice President for Research,
The Ohio State University
|
| |
|
|
|